CAM-FAP-Ac-225

N/A

Report date: 2025/10/20 14:18:34

Base Information

Drug NameCAM-FAP-Ac-225

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionFibroblast activation protein alpha binders

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesPrecirix NV/SA

China Registration ClassN/A

Develop Information

Active CompaniesPrecirix NV/SA

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A